Loading clinical trials...
Loading clinical trials...
Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Conditions
Interventions
Nipocalimab
Placebo
+1 more
Locations
112
United States
Neuromuscular Research Center and Clinic
Paradise Valley, Arizona, United States
HonorHealth Neurology
Scottsdale, Arizona, United States
University of Southern California
Los Angeles, California, United States
Stanford University
Palo Alto, California, United States
Care Access Research
Pasadena, California, United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Start Date
July 15, 2021
Primary Completion Date
November 17, 2023
Completion Date
March 30, 2029
Last Updated
March 3, 2026
NCT06312644
NCT06754020
NCT07089121
NCT07247279
NCT07246564
NCT07470151
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions